N-(((2,6-disubstituted)phenyl)-N-diarylalkyl)ureas as antihyperl

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514336, 514342, 514345, 514353, 514357, 514444, 514445, 514447, 514438, 514585, 514586, 514587, 514596, 514598, 514824, 564 27, 564 28, 564 29, 564 26, 564 48, 564 52, 546261, 546265, 546284, 546291, C07C27534, C07C27528, A61K 3117

Patent

active

051168480

ABSTRACT:
Certain N-2,6-dialkyl- or N-2,6-dialkoxphenyl-N'-diarylalkylurea compounds are potent inhibitors of the enzyme acyl CoA:cholesterol acyltransferase (ACAT), and are thus useful agents for the treatment of hypercholesterolemia or atherosclerosis with urea and thiourea compounds.

REFERENCES:
patent: 2911393 (1959-11-01), Brooks et al.
patent: 3028391 (1962-04-01), Rorig
patent: 4387105 (1983-06-01), DeVries et al.
patent: 4387106 (1983-06-01), DeVries et al.
patent: 4397868 (1983-08-01), DeVries
patent: 4410697 (1983-10-01), Torok et al.
patent: 4473579 (1984-09-01), DeVries et al.
patent: 4623662 (1986-11-01), DeVries

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

N-(((2,6-disubstituted)phenyl)-N-diarylalkyl)ureas as antihyperl does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-(((2,6-disubstituted)phenyl)-N-diarylalkyl)ureas as antihyperl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(((2,6-disubstituted)phenyl)-N-diarylalkyl)ureas as antihyperl will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-420038

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.